Concepedia

TOSHIKAZU OKI

TO

Statistics

Publications

176

Citations

7.6K

H-Index

46

Active since

1967

Affiliations

Bristol-Myers Squibb (Germany)(Current)

Bristol-Myers Squibb (Japan)

Toyama Prefectural University

Microbial Chemistry Research Foundation

Tamagawa University

TOSHIKAZU OKI is an author at Bristol-Myers Squibb (Germany) specializing in pharmacology, medicine, and biochemistry.

Top concepts

MedicinePharmacologyBiochemistryNatural SciencesMicrobiologyDrug DiscoveryDrug ResistanceAntimicrobial ResistanceAntibioticsBiosynthesis

Publications per year

1967–2010

176

Publications

176

Crystal and molecular structure of dynemicin A: a novel 1,5-diyn-3-ene antitumor antibiotic

MASATAKA KONISHI, HIROAKI OHKUMA, Takashi Tsuno et al. · Journal of the American Chemical Society · 1990 · 444 citations

Altmetric Attention Score, Molecular Biology, Antimicrobial Chemotherapy +21

Dynemicin A, a novel antibiotic with the anthraquinone and 1,5-diyn-3-ene subunit.

MASATAKA KONISHI, HIROAKI OHKUMA, Kiyoshi Matsumoto et al. · The Journal of Antibiotics · 1989 · 299 citations · Full text

Antimicrobial Drug Discovery, 1,5-Diyn-3-ene Subunit, Antibiotics +14

New anthracycline antibiotics.

TOSHIKAZU OKI · PubMed · 1977 · 228 citations

New antitumor antibiotics, aclacinomycins A and B.

TOSHIKAZU OKI, Yasue Matsuzawa, Akihiro Yoshimoto et al. · The Journal of Antibiotics · 1975 · 224 citations · Full text

Antimicrobial Drug Discovery, New Antitumor Antibiotics, Antibiotics +10

Epoxomicin, a new antitumor agent of microbial origin.

Minoru Hanada, Koko Sugawara, KEIKO KANETA et al. · The Journal of Antibiotics · 1992 · 210 citations · Full text

Rows per page

1–5 of 176